Id |
Weergavenaam |
Naam |
Ingangsdatum |
Type |
1.3.6.1.4.1.19376.1.3.1.6 |
IHE Laboratory Observation |
ihe-LaboratoryObservation |
2008‑08‑08 |
|
1.3.6.1.4.1.19376.1.5.3.1.3.1.2 |
CCDA2 Reason for Referral Section |
ccda2-ReasonforReferralSection |
2013‑09‑01 |
|
1.3.6.1.4.1.19376.1.5.3.1.4.2 |
IHE Annotation Comment |
ihe-AnnotationComment |
2008‑08‑08 |
|
2.16.840.1.113883.2.4.3.11.60.2.10.1 |
GEBB Encounter Activity |
gebb-EncounterActivity |
2013‑12‑31 |
|
2.16.840.1.113883.2.4.3.11.60.2.10.2 |
GEBB Service Delivery Location |
gebb-ServiceDeliveryLocation |
2013‑12‑31 |
|
2.16.840.1.113883.2.4.3.11.60.2.10.3 |
GEBB Indication |
gebb-Indication |
2013‑01‑31 |
|
2.16.840.1.113883.2.4.3.11.60.2.10.4 |
GEBB Encounter Diagnosis |
gebb-EncounterDiagnosis |
2013‑01‑31 |
|
2.16.840.1.113883.2.4.3.11.60.2.10.5 |
GEBB Laboratory Observation |
gebb-LaboratoryObservation |
2014‑03‑31 |
|
2.16.840.1.113883.2.4.3.11.60.2.10.6 |
GEBB Comment Activity |
gebb-CommentActivity |
2014‑03‑31 |
|
2.16.840.1.113883.2.4.3.11.60.2.10.7 |
GEBB Result Observation |
gebb-ResultObservation |
2013‑01‑31 |
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.115 |
MP Related Prescription |
RelatedPrescription |
2013‑12‑21 |
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.116 |
MP Medication Information |
MedicationInformation |
2013‑12‑21 |
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.117 |
MP Active Ingredient CDA |
ActiveIngredientCDA |
2013‑12‑21 |
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.118 |
MP Ingredient Material Kind CDA |
IngredientMaterialKindCDA |
2013‑05‑21 |
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.119 |
MP Other Ingredient CDA |
OtherIngredientCDA |
2013‑05‑21 |
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9005 |
MP Medication or Material Code |
MedicationOrMaterialCode |
2013‑05‑21 |
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9006 |
Usable Period and Frequency |
UsablePeriodandFrequency |
2013‑05‑21 |
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9016 |
MP Medication or Material Code Ext |
MedicationOrMaterialCodeExt |
2013‑05‑21 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.1 |
VZVZ Verwijzing Huisarts Zorggroep |
verwijzingHuisartsZorggroep |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.2 |
VZVZ Overdracht Zorggroep Huisarts |
overdrachtZorggroepHuisarts |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.3 |
VZVZ Generieke Query Zorggegevens |
generiekeQueryZorggegevens |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.4 |
VZVZ Batch antwoord |
batchAntwoord |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.5 |
VZVZ Opvragen Labuitslagen |
opvragenLabUitslagen |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.6 |
VZVZ Opleveren Labuitslagen |
opleverenLabUitslagen |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.6 |
VZVZ Opleveren Labuitslagen |
opleverenLabUitslagen |
2014‑08‑18 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.7 |
VZVZ Opvragen Algemene Uitslagen |
opvragenAlgemeneUitslagen |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.8 |
VZVZ Opleveren Algemene Uitslagen |
opleverenAlgemeneUitslagen |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.8 |
VZVZ Opleveren Algemene Uitslagen |
opleverenAlgemeneUitslagen |
2014‑08‑18 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9 |
VZVZ Opvragen Contactmomenten |
opvragenContactmomenten |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.10 |
VZVZ Opleveren Contactmomenten |
opleverenContactmomenten |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.10 |
VZVZ Opleveren Contactmomenten |
opleverenContactmomenten |
2014‑08‑18 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.11 |
VZVZ Opvragen Medicatievoorschriften |
opvragenVoorschriftenLijst |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.12 |
VZVZ Opleveren Medicatievoorschriften |
opleverenVoorschriftenLijst |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.12 |
VZVZ Opleveren Medicatievoorschriften |
opleverenVoorschriftenLijst |
2014‑08‑18 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.50 |
KEZO Clinical Document Verwijzing |
kezo-clinicaldocument-verwijzing |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.51 |
KEZO Clinical Document Overdracht |
kezo-clinicaldocument-overdracht |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.90 |
VZVZ Ontvangstbevestiging |
Ontvangstbevestiging |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.91 |
VZVZ TransmissionWrapper Accept Ack |
TransmissionWrapperMCCI_MT000200 |
2014‑01‑13 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.101 |
KEZO CDA recordTarget |
CDArecordTarget |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.102 |
KEZO CDA author |
CDAauthor |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.103 |
KEZO CDA custodian |
CDAcustodian |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.104 |
KEZO CDA Informant |
CDAinformant |
2014‑08‑18 13:50:32 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.105 |
KEZO CDA recordTarget BSN only |
CDArecordTargetBSNOnly |
2014‑08‑18 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.200 |
KEZO Generieke Groepering |
kezo-genericwrapper |
2014‑07‑21 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.200 |
KEZO Generieke Groepering |
kezo-genericwrapper |
2014‑08‑18 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.201 |
KEZO Contactmoment |
kezo-Contactmoment |
2013‑12‑31 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.202 |
KEZO Algemene bepaling |
kezo-Algemenebepaling |
2013‑12‑31 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.203 |
KEZO Labbepaling |
kezo-Labbepaling |
2014‑04‑03 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.204 |
KEZO Voorschrift |
kezo-Voorschrift |
2014‑04‑30 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.205 |
KEZO Indicatie Diagnose |
kezo-IndicatieDiagnose |
2014‑04‑30 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.206 |
KEZO Verwijzing |
kezo-PatientReferralAct |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.301 |
KEZO Clinical Information Section |
kezo-ClinicalInformation |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.302 |
KEZO Summary Section |
kezo-Summary |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.303 |
KEZO Reason for Referral Section |
kezo-Reasonforreferral |
2014‑09‑10 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9001 |
PART CDA Person |
CDAPerson |
2013‑12‑22 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9002 |
PART CDA Organization |
CDAOrganization |
2011‑12‑19 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9003 |
PART CDA Assigned Entity |
CDAAssignedEntity |
2013‑12‑22 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9005 |
PART CDA Observation Reference Range |
CDAObservationReferenceRange |
2013‑12‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9006 |
PART CDA Specimen |
CDASpecimen |
2014‑04‑03 15:10:18 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9007 |
PART CDA Participant (Body) |
CDAParticipantBody |
2014‑04‑03 15:25:16 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9008 |
PART CDA Device |
CDADevice |
2014‑04‑03 15:47:26 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9009 |
PART CDA PlayingEntity |
CDAPlayingEntity |
2014‑04‑03 15:47:46 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9010 |
PART CDA Subject (Body) |
CDASubjectBody |
2014‑04‑03 15:50:23 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9011 |
PART CDA Author (Body) |
CDAAuthorBody |
2014‑04‑03 16:28:02 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9012 |
PART CDA Performer (Body) |
CDAPerformerBody |
2014‑04‑03 16:28:20 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9013 |
PART Contact reference |
Contactreference |
2014‑04‑10 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9014 |
PART Concern reference |
Concernreference |
2014‑04‑10 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9015 |
PART CDA Responsible Party (Body) |
CDAResponsiblePartyBody |
2014‑04‑30 10:28:20 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9016 |
PART CDA typeId |
CDAtypeId |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9017 |
PART CDA id |
CDAid |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9018 |
PART CDA title |
CDAtitle |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9019 |
PART CDA effectiveTime |
CDAeffectiveTime |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9020 |
PART CDA confidentialityCode |
CDAconfidentialityCode |
2014‑06‑27 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9021 |
PART CDA RelatedEntity |
CDARelatedEntity |
2014‑08‑18 13:56:46 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9022 |
VZVZ AttentionLine ContextCode |
AttentionLineContextCode |
2014‑09‑10 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9023 |
VZVZ ControlAct Overseer Person |
ControlActOverseerPerson |
2014‑09‑22 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9024 |
VZVZ ControlAct Overseer Person MCAI |
ControlActOverseerPersonMCAI |
2014‑09‑22 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9025 |
KEZO PART CDA Author (Body) |
CDAAuthorBody-kezo |
2014‑04‑03 16:28:02 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9026 |
PART CDA realmCode |
CDArealmCode |
2014‑10‑06 |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9027 |
PART CDA languageCode |
CDAlanguageCode |
2014‑10‑06 |
|
2.16.840.1.113883.10.20.22.4.2.2 |
CCDA2 Result Observation |
ccda2-ResultObservation |
2013‑01‑31 |
|
2.16.840.1.113883.10.20.22.4.19.2 |
CCDA2 Indication (V2) |
ccda2-IndicationV2 |
2013‑12‑31 |
|
2.16.840.1.113883.10.20.22.4.32 |
CCDA2 Service Delivery Location |
ccda2-ServiceDeliveryLocation |
2013‑12‑31 |
|
2.16.840.1.113883.10.20.22.4.49.2 |
CCDA2 Encounter Activity |
ccda2-EncounterActivity |
2013‑12‑31 |
|
2.16.840.1.113883.10.20.22.4.64 |
CCDA Comment Activity |
ccda2-CommentActivity |
2014‑03‑31 |
|
2.16.840.1.113883.10.20.22.4.80.2 |
CCDA2 Encounter Diagnosis (V2) |
ccda2-EncounterDiagnosisV2 |
2013‑12‑31 |
|
2.16.840.1.113883.10.20.22.4.119 |
CCDA2 Author Participation |
ccda2-AuthorParticipation |
2014‑03‑26 |
|
2.16.840.1.113883.10.20.22.4.122 |
CCDA2 Act Reference |
ccda2-ActReference |
2013‑09‑01 |
|
2.16.840.1.113883.10.20.22.4.140 |
CCDA2 Patient Referral Act |
ccda2-PatientReferralAct |
2013‑09‑01 |
|